Brief: Galecto Reports First Quarter Operating And Financial Results

Damora Therapeutics

29/04/2022 14:39

April 29 (Reuters) - Galecto Inc  GLTO.O :
    * GALECTO REPORTS FIRST QUARTER OPERATING AND FINANCIAL
RESULTS
    * Q1 LOSS PER SHARE $0.67
    * CASH, CASH EQUIVALENTS, AND INVESTMENTS AS OF MARCH 31,
2022
WERE APPROXIMATELY $101.8 MILLION
    * GALECTO- ANTICIPATES CASH, CASH EQUIVALENTS & INVESTMENTS
WILL
BE SUFFICIENT TO FUND OPERATING EXPENSES,CAPITAL REQUIREMENTS
INTO SECOND HALF OF 2024

Source text for Eikon:  ID:nGNX3gbh 
Further company coverage:  GLTO.O 

 ((Reuters.Briefs@thomsonreuters.com;))